Introduction
Basal cell carcinomas are the commonest skin malignancy in Caucasians, accounting for approximately 70% of skin cancers. The natural history of basal cell carcinoma is one of local invasion and recurrence, and metastases are rare. Only 109 cases of documented metastatic basal cell carcinoma have been reported (Safai, 1977) Development of metastatic basal cell carcinomas is associated with a poor prognosis with a median survival time of approximately 10 months (Costanza et al., 1974) . Systemic chemotherapy has not been commonly used in basal cell carcinomas although topical cytotoxics have been used with good results for non-metastasizing lesions, and 5-fluorouracil has been particularly valuable used in this way (Klein, 1968) . In view of the poor prognosis in the present case it was felt that systemic chemotherapy was justified in spite of the poor results reported to date. Ten reported cases have been treated with cytotoxic chemotherapy and the drugs most commonly used have been bleomycin, methotrexate and 5-fluorouracil. None of these 10 cases has responded to the chemotherapy and thus the choice of drugs in this case was purely speculative. The authors had previously noted that, in some patients, concomitant basal cell carcinomas had sometimes regressed during treatment for squamous cell carcinoma of the head and neck. The schedule which the authors had been using for head and neck cancers at that stage was the one previously described with methotrexate, bleomycin, and vincristine and this was therefore used as initial chemotherapy, but produced no benefit. These lesions are known to be sensitive to radio-therapy and it might therefore be thought that the so-called radiomimetic drugs might be effective. Only 2 cases have been reported in which alkylating agents have been used (Costanza et al., 1974; Assor, 1967) . No response occurred in the first case which was a lesion involving bone treated with mechlorethamine hydrochloride. The second patient had pulmonary metastases which were initially treated with 5-fluorouracil followed by bleomycin. Cyclophosphamide and methotrexate were only used preterminally without success. The present authors therefore felt justified in using an alkylating agent, and cyclophosphamide was administered; they also gave cis-platinum, which is considered by some to be a bifunctional alkylating agent. The decrease in the size of the lesions which was observed and the improvement in the patient's symptoms confirm that these drugs have been effective.
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